Found: 6
Select item for more details and to access through your institution.
Detailed assessment of NOD2/CARD15 exonic variation in inflammatory bowel disease in Scotland: implications for disease pathogenesis.
- Published in:
- Genes & Immunity, 2008, v. 9, n. 6, p. 556, doi. 10.1038/gene.2008.44
- By:
- Publication type:
- Article
NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?
- Published in:
- Genes & Immunity, 2004, v. 5, n. 5, p. 417, doi. 10.1038/sj.gene.6364111
- By:
- Publication type:
- Article
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease.
- Published in:
- Nature Communications, 2016, v. 7, n. 11, p. 13507, doi. 10.1038/ncomms13507
- By:
- Publication type:
- Article
Autophagy: from basic science to clinical application.
- Published in:
- Mucosal Immunology (1933-0219), 2009, v. 2, n. 4, p. 315, doi. 10.1038/mi.2009.20
- By:
- Publication type:
- Article
The intermediate filament protein, vimentin, is a regulator of NOD2 activity.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 1, p. 30
- By:
- Publication type:
- Article
Anti- Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
- Published in:
- Clinical & Experimental Immunology, 2004, v. 135, n. 3, p. 490, doi. 10.1111/j.1365-2249.2003.02392.x
- By:
- Publication type:
- Article